Anti-Mouse CD45.1 eFluor® 450

Also known as: SJL, Ly5.1

Clone: A20

RUO: For Research Use Only. Not for use in diagnostic procedures.

SKU# 48-0453

Cat. No. Size
48-0453-80 25 ug
48-0453-82 100 ug
Please inquire about custom configurations or bulk packaging.

To enable ordering, please select your country. Cookies will need to be enabled to continue on our website. View our Privacy Policy.

Data for Anti-Mouse CD45.1 eFluor® 450 (Pacific Blue® replacement).

Staining of SJL splenocytes with 0.25 ug of Mouse IgG2a kappa Isotype Control eFluor® 450 (cat....View More

  • Data for Anti-Mouse CD45.1 eFluor® 450 (Pacific Blue® replacement).
Description

Description: The A20 monoclonal antibody reacts with the mouse CD45 molecule, the leukocyte common antigen (LCA) in CD45.1-expressing mouse strains. The strains that express CD45.1 include SJL/J, DA, STS/A and RIII. CD45.1 is expressed by all leukocytes in these strains.

Details
Host Mouse
Isotype IgG2a, kappa
Reactivity Mouse
Conjugate eFluor 450
Laser Violet Laser
Emit 450 nm
Excite 405 nm
Reported Applications Flow Cytometric Analysis
Documentation
TDS Link Download TDS
Additional Formats
Cat. No. Name Excite Emit Application Reg.
15-0453 Anti-Mouse CD45.1 PE-Cyanine5 488 - 561 nm FC RUO
47-0453 Anti-Mouse CD45.1 APC-eFluor® 780 633 - 647 nm 780 nm FC RUO
11-0453 Anti-Mouse CD45.1 FITC 488 nm 518 nm FC RUO
12-0453 Anti-Mouse CD45.1 PE 488 - 561 nm 575 nm FC RUO
25-0453 Anti-Mouse CD45.1 PE-Cyanine7 488 - 561 nm 775 nm FC RUO
14-0453 Anti-Mouse CD45.1 Purified FC, IP RUO
93-0453 Anti-Mouse CD45.1 eFluor® 605NC 350 - 590 nm 605 nm FC RUO
45-0453 Anti-Mouse CD45.1 PerCP-Cyanine5.5 488 nm FC RUO
13-0453 Anti-Mouse CD45.1 Biotin FC RUO
17-0453 Anti-Mouse CD45.1 APC 633 - 647 nm 660 nm FC RUO
19-0453 Anti-Mouse CD45.1 Cy5 633 - 647 nm 670 nm FC RUO
Related Products
Cat. No. Name Excite Emit Application Reg.
48-4724 Mouse IgG2a K Isotype Control eFluor® 450 405 nm 450 nm FC RUO
References

References:
Shen, F-W. (1981). "Monoclonal antibodies to mouse lymphocyte differentiation alloantigens. In Monoclonal antibodies and T cell Hybridomas; Perspective and technical advances, eds. Hammerling, G.J., U. Hammerling, and J.F. Kearney": 25-31.